The Role of Community Health Centers in Addressing the Opioid Epidemic
Issue Brief
Seth, P., Scholl, L., Rudd, R. A., & Bacon, S. (2018). Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants-United States, 2015-2016. MMWR. Morbidity and Mortality Weekly Report, 67(12), 349-358. https://www.cdc.gov/mmwr/volumes/67/wr/mm6712a1.htm?s_cid=mm6712a1_w#T1_down
Rosenbaum, S., Tolbert, J., Sharac, J., Shin, P., Gunsalus, R. & Zur, J. (2018). Community Health Centers: Growing Importance in a Changing Health Care System. Kaiser Family Foundation. https://www.kff.org/medicaid/issue-brief/community-health-centers-growing-importance-in-a-changing-health-care-system/
Julia Zur and Jennifer Tolbert, “The Opioid Epidemic and Medicaid’s Role in Facilitating Access to Treatment,” Kaiser Family Foundation, accessed June 2018, https:/”www.kff.org/medicaid/issue-bief/the-opioid-epidemic-and-medicaids-role-in-facilitating-access-to-treatment/.
“The Opioid Epidemic and Medicaid’s Role in Treatment: A Look at Changes Over Time,” Kaiser Family Foundation,” accessed June 2018, https://www.kff.org/slideshow/the-opioid-epidemic-and-medicaids-role-in-treatment-a-look-at-changes-over-time/
“Status of State Action on the Medicaid Expansion Decision,” accessed June 2018, https://www.kff.org/health-reform/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act.
Health Resources and Services Administration, “Uniform Data System: Reporting Instructions for 2016 Health Center Data,” (p. 54), accessed June 2018, https://www.bphc.hrsa.gov/datareporting/reporting/2016udsreportingmanual.pdf.
Health Resources and Services Administration, “2010 Health center data: National data,” accessed June 2018, https://bphc.hrsa.gov/uds/view.aspx?q=tall&year=2010&state; Health Resources and Services Administration, “2016 health center data: National data,” accessed June 2018, https://bphc.hrsa.gov/uds/view.aspx?q=tall&year=2016&state=.
“Medical providers treating patients with substance use diagnoses remain reported on Lines 1 through 10 (p. 54).” “Because substance abuse is also seen as a mental health diagnosis, it is permissible to count the visit under mental health (p. 63).” Health Resources and Services Administration, “Uniform Data System: Reporting Instructions for 2016 Health Center Data,” accessed June 2018, https://www.bphc.hrsa.gov/datareporting/reporting/2016udsreportingmanual.pdf.
Substance Abuse and Mental Health Services Administration, “Medication-Assisted Treatment (MAT)” https://www.samhsa.gov/medication-assisted-treatment (accessed June 4, 2018).
Rosenbaum, S., Tolbert, J., Sharac, J., Shin, P., Gunsalus, R. & Zur, J. (2018). Community Health Centers: Growing Importance in a Changing Health Care System. Kaiser Family Foundation. https://www.kff.org/medicaid/issue-brief/community-health-centers-growing-importance-in-a-changing-health-care-system/
Substance Abuse and Mental Health Services Administration, “Medication-Assisted Treatment (MAT)” https://www.samhsa.gov/medication-assisted-treatment (accessed June 4, 2018).
Colleen M. Grogan, et al., “Survey Highlights Differences in Medicaid Coverage for Substance Use Treatment and Opioid Use Disorder Medications,” Health Affairs 35, no. 12 (Dec. 2016):2289-2296, http://content.healthaffairs.org/content/35/12/2289.full
Kathleen Gifford et al., Medicaid Moving Ahead in Uncertain Times: Results from a 50-State Medicaid Budget Survey for State Fiscal Years 2017 and 2018,” Kaiser Family Foundation, accessed June 2018, https://www.kff.org/medicaid/report/medicaid-moving-ahead-in-uncertain-times-results-from-a-50-state-medicaid-budget-survey-for-state-fiscal-years-2017-and-2018/.
Ibid
Office of Management and Budget, “Efficient, Effective, Accountable: An American Budget,” accessed June 2018, https://www.whitehouse.gov/wp-content/uploads/2018/02/budget-fy2019.pdf.
Substance Abuse and Mental Health Services Administration, “Buprenorphine Waiver Management,” https://www.samhsa.gov/programs-campaigns/medication-assisted-treatment/training-materials-resources/buprenorphine-waiver (accessed June 4, 2018).
Health Resources and Services Administration, “Electronic Health Record Capabilities and Quality Recognition: National data,” accessed June 2018, https://bphc.hrsa.gov/uds/datacenter.aspx?q=tehr&year=2016&state=&fd=.
U.S. Congress, Senate, Comprehensive Addiction and Recovery Act of 2016, S.524, 114th Congress, https://www.congress.gov/114/plaws/publ198/PLAW-114publ198.pdf.
Heide Jackson et al., “Cost Effectiveness of Injectable Extended Release Naltrexone Compared to Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence,” Substance Abuse 36, no. 2 (2015):226-231, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470733/
Rosenbaum, S., Tolbert, J., Sharac, J., Shin, P., Gunsalus, R. & Zur, J. (2018). Community Health Centers: Growing Importance in a Changing Health Care System. Kaiser Family Foundation. https://www.kff.org/medicaid/issue-brief/community-health-centers-growing-importance-in-a-changing-health-care-system/
Substance Abuse and Mental Health Services Administration, An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence (Rockville, MD: US Department of Health and Human Services, 2012), https://www.integration.samhsa.gov/Intro_To_Injectable_Naltrexone.pdf
Substance Abuse and Mental Health Services Administration, Report to Congress on the Nation’s Substance Abuse and Mental Health Workforce Issues (Rockville, MD: US Department of Health and Human Services, January 2013), https://store.samhsa.gov/shin/content/PEP13-RTC-BHWORK/PEP13-RTC-BHWORK.pdf.
“The Opioid Epidemic and Medicaid’s Role in Treatment: A Look at Changes Over Time,” Kaiser Family Foundation,” accessed June 2018, https://www.kff.org/slideshow/the-opioid-epidemic-and-medicaids-role-in-treatment-a-look-at-changes-over-time/
Julia Zur and Jennifer Tolbert, “The Opioid Epidemic and Medicaid’s Role in Facilitating Access to Treatment,” Kaiser Family Foundation, accessed June 2018, https://www.kff.org/medicaid/issue-bief/the-opioid-epidemic-and-medicaids-role-in-facilitating-access-to-treatment/.
U.S. Department of Health and Human Services. “HHS awards $94 million to health centers to help treat the prescription opioid abuse and heroin epidemic in America,” accessed June 5, 2018, https://www.hhs.gov/hepatitis/blog/2016/03/17/hhs-awards-94-million-to-health-centers-to-help-treat-the-prescription-opioid-abuse-and-heroin-epidemic-in-america.html
U.S. Department of Health and Human Services. “HRSA awards $200 million to health centers nationwide to tackle mental health and fight the opioid overdose crisis,” accessed June 5, 2018, https://www.hhs.gov/about/news/2017/09/14/hrsa-awards-200-million-to-health-centers-nationwide.html
U.S. Department of Health and Human Services. “FY 2018 expanding access to quality substance use disorder and mental health services (SUD-MH) supplemental funding technical assistance (HRSA-18-118),” accessed July 10, 2018, https://bphc.hrsa.gov/programopportunities/fundingopportunities/sud-mh/index.html
Substance Abuse and Mental Health Services Administration, “Naloxone” https://www.samhsa.gov/medication-assisted-treatment/treatment/naloxone (accessed June 4, 2018).
“States Reporting Medicaid FFS Pharmacy Benefit Management Strategies for Naloxone in Place,” Kaiser Family Foundation, accessed June 2018, https://www.kff.org/medicaid/state-indicator/states-reporting-medicaid-ffs-pharmacy-benefit-management-strategies-for-naloxone-in-place
Ibid
Centers for Disease Control and Prevention, “What States Need to Know about PDMPs,” https://www.cdc.gov/drugoverdose/pdmp/states.html (accessed June 4, 2018).